GJA1 and triple-negative breast carcinoma: We and others have reported that bisphosphonates also promoted osteocytes, the predominant bone cell, to release ATP to the extracellular environment through Cx43 hemichannels and that this decreases triple-negative breast cancer growth in bone (15–17, 55).